A phase I trial of lapatinib in combination with carboplatin in patients with platinum sensitive recurrent epithelial ovarian cancer

被引：0
|
作者：
Kimball, K. J. [1 ]
Numnum, T. M. [1 ]
Estes, J. M. [1 ]
Kirby, T. O. [1 ]
Barnes, M. N. [1 ]
Alvarez, R. D. [1 ]
机构：
[1] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14106
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
    Robert J. Morgan
    Timothy W. Synold
    David Gandara
    Franco Muggia
    Sidney Scudder
    Eddie Reed
    Kim Margolin
    James Raschko
    Lucille Leong
    Stephen Shibata
    Merry Tetef
    Steven Vasilev
    Kathryn McGonigle
    Jeff Longmate
    Yun Yen
    Warren Chow
    George Somlo
    Mary Carroll
    James H. Doroshow
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 283 - 289
  • [42] Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
    Morgan, RJ
    Synold, TW
    Gandara, D
    Muggia, F
    Scudder, S
    Reed, E
    Margolin, K
    Raschko, J
    Leong, L
    Shibata, S
    Tetef, M
    Vasilev, S
    McGonigle, K
    Longmate, J
    Yen, Y
    Chow, W
    Somlo, G
    Carroll, M
    Doroshow, JH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (04) : 283 - 289
  • [43] Nedaplatin and paclitaxel comparedwith carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer
    Ge, L.
    Li, N.
    Wu, L. Y.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 33 - 34
  • [44] Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer
    Ge, Li
    Li, Ning
    Yuan, Guang-Wen
    Sun, Yang-Chun
    Wu, Ling-Ying
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (06): : 1074 - 1082
  • [45] A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer
    Alvarez-Secord, A.
    Berchuck, A.
    Higgins, R.
    Nycum, L.
    Kohler, M.
    Puls, L.
    Holloway, R.
    Lewandowski, G.
    Valea, F.
    Havrilesky, L.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S3 - S3
  • [46] Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer.
    Vorobiof, DA
    Rapoport, B
    Slabber, C
    Eek, R
    Cohen, G
    Alberts, AS
    McMichael, GB
    Raats, J
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 471S - 471S
  • [47] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Ritsu Yamamoto
    Masanori Kaneuchi
    Masashi Nishiya
    Yukiharu Todo
    Mahito Takeda
    Kazuhira Okamoto
    Hiroaki Negishi
    Noriaki Sakuragi
    Seiichiro Fujimoto
    Takeshi Hirano
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 137 - 142
  • [48] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Yamamoto, R
    Kaneuchi, M
    Nishiya, M
    Todo, Y
    Takeda, M
    Okamoto, K
    Negishi, H
    Sakuragi, N
    Fujimoto, S
    Hirano, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 137 - 142
  • [49] A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer
    Gerald S. Falchook
    Stacy Moulder
    Aung Naing
    Jennifer J. Wheler
    David S. Hong
    Sarina A. Piha-Paul
    Apostolia M. Tsimberidou
    Siqing Fu
    Ralph Zinner
    Filip Janku
    Yunfang Jiang
    Mei Huang
    Kristin L. Parkhurst
    Razelle Kurzrock
    Investigational New Drugs, 2015, 33 : 177 - 186
  • [50] A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer
    Falchook, Gerald S.
    Moulder, Stacy
    Naing, Aung
    Wheler, Jennifer J.
    Hong, David S.
    Piha-Paul, Sarina A.
    Tsimberidou, Apostolia M.
    Fu, Siqing
    Zinner, Ralph
    Janku, Filip
    Jiang, Yunfang
    Huang, Mei
    Parkhurst, Kristin L.
    Kurzrock, Razelle
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (01) : 177 - 186
12345